or
Remember me
Back
Curaleaf has over 625 million shares on the market. Along with trulieve on the one year chart has declined both 52 percent and 71 percent respectively. Curaleaf couldn't raise money through Banking investment if they tried. Their institutional investors have bailed leaving less then 0.27 ownership after the Russian Oligarchy connection. You know what that means? Curaleaf burning cash no cash free flow guidance anytime soon and will dilute again to raise funds. It's trades on a small exchange which thus far protected it from the real collapse coming. Insiders have propped it up in the hopes "this too shall pass". I'm rooting for Curaleaf if they can disassociate from all blood money connections. At this time however it remains one of the worst positions to take. Don't listen to the paid Canadian LP bashers. Take a look at MedMen a company Tilray invested in, the shorts like to attack it's credentials but can't explain why it has 9 times more institutional investors then Curaleaf. Fact check yourself. Tilray is the global brand 4 times the cash 3 times the global infrastructure to capture new markets then Curaleaf. Tilray is also bumping up to double digit domestic Canadian market share. LongTilray
A daily snapshot of everything from market open to close.